La tomographie par emission de positons au 18F-FDG en pathologie renale non oncologique : indications actuelles et perspectives.

HANSSEN, Oriane; LOVINFOSSE, Pierre; WEEKERS, Laurent; Hustinx, Roland; Jouret, François

doi:10.1016/j.nephro.2018.11.007

Article (Scientific journals)

La tomographie par emission de positons au 18F-FDG en pathologie renale non oncologique : indications actuelles et perspectives.

HANSSEN, Oriane; LOVINFOSSE, Pierre; WEEKERS, Laurent et al.

2019 • In Néphrologie et Thérapeutique

Peer Reviewed verified by ORBi

Permalink
https://hdl.handle.net/2268/237743

DOI
10.1016/j.nephro.2018.11.007

PubMed
30982747

Files (1)Send to Details Statistics Bibliography Similar publications

Files

Full Text

La tomographie par émission de positons au 18F-FDG en pathologie rénale non oncologique - indications actuelles et perspectives.pdf

Publisher postprint (951.23 kB)

Request a copy

All documents in ORBi are protected by a user license.

Send to

RIS BibTex APA Chicago Permalink X Linkedin

Details

Keywords :

Fluorodeoxyglucose F18; Nephrology; Nephrologie; Positron emission tomography; Tomographie par emission de positons

Abstract :

[en] Positron emission tomography combined with computed tomography (PET/CT) is a nuclear imaging technique which provides anatomical and functional information. PET/CT is increasingly used in non-oncological nephrology since conventional radiological approaches after injection of contrast agents are relatively contra-indicated in patients with chronic kidney disease (CKD). PET/CT after i.v. injection of (18)F-fluoro-deoxy-glucose (FDG) is not toxic and is characterized by a high sensitivity. The level of irradiation ( approximately 5mSv) is acceptable. CKD does not significantly influence tissue uptake of (18)F-FDG. The purpose of the present review aims at detailing the non-oncological indications of (18)F-FDG PET/CT in general nephrology and after kidney transplantation. Particularly, (18)F-FDG PET/CT appears useful in the diagnosis of cyst infection in patients with autosomal dominant polycystic kidney disease, as well as in the characterization of retroperitoneal fibrosis. In kidney transplant recipients, (18)F-FDG PET/CT may help in the diagnostic work-up of suspected acute rejection, thereby eventually avoiding unnecessary kidney transplant biopsy. Perspectives in (18)F-FDG PET/CT imaging are discussed, including innovative approaches of image analysis.

Disciplines :

Radiology, nuclear medicine & imaging
Urology & nephrology

Author, co-author :

HANSSEN, Oriane ; CHU DE LIEGE > NEPHROLOGIE > TRANSPLANTATION

LOVINFOSSE, Pierre ; CHU DE LIEGE > DEPARTEMENT DE PHYSIQUE MEDICALE > MEDECINE NUCLEAIRE ET IMAGERIE ONCOLOGIQUE

WEEKERS, Laurent ; Centre Hospitalier Universitaire de Liège - CHU > Département de médecine interne > Service de néphrologie

Hustinx, Roland ; CHU DE LIEGE > DEPARTEMENT DE PHYSIQUE MEDICALE > MEDECINE NUCLEAIRE ET IMAGERIE ONCOLOGIQUE

Jouret, François ; Université de Liège - ULiège > Cardiovascular Sc.-Lab. of Translational Res. in Nephrology

Language :

French

Title :

La tomographie par emission de positons au 18F-FDG en pathologie renale non oncologique : indications actuelles et perspectives.

Alternative titles :

[en] (18)F-FDG positron emission tomography in non-oncological renal pathology: Current indications and perspectives

Publication date :

2019

Journal title :

Néphrologie et Thérapeutique

ISSN :

1769-7255

eISSN :

1872-9177

Peer reviewed :

Peer Reviewed verified by ORBi

Commentary :

Available on ORBi :

since 30 June 2019

Statistics

Number of views

90 (10 by ULiège)

Number of downloads

8 (6 by ULiège)

More statistics

Scopus citations^®

Scopus citations^®
without self-citations

OpenCitations

OpenAlex citations

Bibliography

Krishnan, N., Perazella, M.A., The Role of PET scanning in the evaluation of patients with kidney disease. Adv Chronic Kidney Dis 24 (2017), 154–161.
Minamimoto, R., Takahashi, N., Inoue, T., FDG-PET of patients with suspected renal failure: standardized uptake values in normal tissues. Ann Nucl Med 21 (2007), 217–222.
Akers, S.R., Werner, T.J., Rubello, D., Alavi, A., Cheng, G., 18F-FDG uptake and clearance in patients with compromised renal function. Nucl Med Commun 37 (2016), 825–832.
Jadoul, A., Lovinfosse, P., Weekers, L., Delanaye, P., Krzesinski, J.M., Hustinx, R., et al. The uptake of 18F-FDG by renal allograft in kidney transplant recipients is not influenced by renal function. Clin Nucl Med 41 (2016), 683–687.
Kode, V., Karsch, H., Osman, M.M., Muzaffar, R., Impact of renal failure on F18-FDG PET/CT Scans. Front Oncol, 7, 2017, 155.
Strauss, L.G., Conti, P.S., The applications of PET in clinical oncology. J Nucl Med 32 (1991), 623–648.
Lucaj, R., Achong, D.M., Concurrent diffuse pyelonephritis and prostatitis: discordant findings on sequential FDG PET/CT and 67Ga SPECT/CT imaging. Clin Nucl Med 42 (2017), 73–75.
Morelle, M., Jaillard, A., Bellevre, D., Collet, G., Petyt, G., 18F-FDG PET/CT in renal infections: evidence of acute pyelonephritis in a horseshoe kidney. Clin Nucl Med 42 (2017), 112–113.
McCammack, K.C., Hawkes, N.C., Silverman, E.D., Paz, D.A., PET/CT appearance of acute pyelonephritis. Clin Nucl Med 38 (2013), e299–e301.
Wan, C.H., Tseng, J.R., Lee, M.H., Yang, L.Y., Yen, T.C., Clinical utility of FDG PET/CT in acute complicated pyelonephritis-results from an observational study. Eur J Nucl Med Mol Imaging 45 (2018), 462–470.
Chebib, F.T., Torres, V.E., Recent advances in the management of autosomal dominant polycystic kidney disease. Clin J Am Soc Nephrol, 2018, 10.2215/CJN.03960318.
De Rechter, S., Breysem, L., Mekahli, D., Is autosomal dominant polycystic kidney disease becoming a pediatric disorder?. Front Pediatr, 5, 2017, 272.
Sallée, M., Rafat, C., Zahar, J.R., Paulmier, B., Grünfeld, J.P., Knebelmann, B., et al. Cyst infections in patients with autosomal dominant polycystic kidney disease. Clin J Am Soc Nephrol 4 (2009), 1183–1189.
Neuville, M., Hustinx, R., Jacques, J., Krzesinski, J.M., Jouret, F., Diagnostic algorithm in the management of acute febrile abdomen in patients with autosomal dominant polycystic kidney disease. PLoS ONE, 11, 2016, e0161277.
Jouret, F., Lhommel, R., Devuyst, O., Annet, L., Pirson, Y., Hassoun, Z., et al. Diagnosis of cyst infection in patients with autosomal dominant polycystic kidney disease: attributes and limitations of the current modalities. Nephrol Dial Transplant 27 (2012), 3746–3751.
Jouret, F., Lhommel, R., Beguin, C., Devuyst, O., Pirson, Y., Hassoun, Z., et al. Positron-emission computed tomography in cyst infection diagnosis in patients with autosomal dominant polycystic kidney disease. Clin J Am Soc Nephrol 6 (2011), 1644–1650.
Bobot, M., Ghez, C., Gondouin, B., Sallée, M., Fournier, P.E., Burtey, S., et al. Diagnostic performance of ((18)F)fluorodeoxyglucose positron emission tomography-computed tomography in cyst infection in patients with autosomal dominant polycystic kidney disease. Clin Microbiol Infect 22 (2016), 71–77.
Kita, Y., Soda, T., Terai, A., Diagnosis and localization of infected renal cyst by diffusion-weighted magnetic resonance imaging in polycystic kidney disease. Int J Urol 16 (2009), 918–919.
Ichioka, K., Saito, R., Matsui, Y., Terai, A., Diffusion-weighted magnetic resonance imaging of infected renal cysts in a patient with polycystic kidney disease. Urology, 70, 2007, 1219.
Suwabe, T., Ubara, Y., Ueno, T., Hayami, N., Hoshino, J., Imafuku, A., et al. Intracystic magnetic resonance imaging in patients with autosomal dominant polycystic kidney disease: features of severe cyst infection in a case-control study. BMC Nephrology, 17, 2016, 170.
Balbo, B.E., Sapienza, M.T., Ono, C.R., Jayanthi, S.K., Dettoni, J.B., Castro, I., et al. Cyst infection in hospital-admitted autosomal dominant polycystic kidney disease patients is predominantly multifocal and associated with kidney and liver volume. Braz J Med Biol Res 47 (2014), 584–593.
Piccoli, G.B., Arena, V., Consiglio, V., Deagostini, M.C., Pelosi, E., Douroukas, A., et al. Positron emission tomography in the diagnostic pathway for intracystic infection in adpkd and “cystic” kidneys. A case series. BMC Nephrol, 12, 2011, 48.
Lantinga, M.A., Drenth, J.P., Gevers, T.J., Diagnostic criteria in renal and hepatic cyst infection. Nephrol Dial Transplant 30 (2015), 744–751.
Kanaan, N., Goffin, E., Pirson, Y., Devuyst, O., Hassoun, Z., Carbohydrate antigen 19-9 as a diagnostic marker for hepatic cyst infection in autosomal dominant polycystic kidney disease. Am J Kidney Dis 55 (2010), 916–922.
Kwon, H.W., Lee, H.Y., Hwang, Y.H., Park, H.C., Ahn, C., Kang, K.W., Diagnostic performance of 18F-FDG-labeled white blood cell PET/CT for cyst infection in patients with autosomal dominant polycystic kidney disease: a prospective study. Nucl Med Commun 37 (2016), 493–498.
Kim, H., Oh, Y.K., Park, H.C., Park, S., Lee, S., Lee, H.Y., et al. Clinical experience with WBC-PET/CT in ADPKD patients with suspected cyst infection: a prospective case series. Nephrology (Carlton) 23 (2018), 661–668.
Bosniak, M., Diagnosis management of patients with complicated cystic lesions of the kidney. AJR 169 (1997), 819–821.
Goldberg, M.A., Mayo-Smith, W.W., Papanicolaou, N., Fischman, A.J., Lee, M.J., FDG PET characterization of renal masses: preliminary experience. Clin Radiol 52 (1997), 510–515.
Kochhar, R., Brown, R.K., Wong, C.O., Dunnick, N.R., Frey, K.A., Manoharan, P., Role of FDG PET/CT in imaging of renal lesions. J Med Imaging Radiat Oncol 54 (2010), 347–357.
Jouret, F., Differding, S., Lhommel, R., Jadoul, M., Lambert, M., A mysterious ‘homesickness’. NDT Plus 5 (2008), 371–372.
Katagiri, D., Masumoto, S., Katsuma, A., Minami, E., Hoshino, T., Inoue, T., et al. Positron emission tomography combined with computed tomography as a new diagnostic tool for acute tubulointerstitial nephritis in oliguric or haemodialysed patients. NDT Plus 3 (2010), 155–159.
Valeyre, D., Prasse, A., Nunes, H., Uzunhan, Y., Brillet, P.Y., Müller-Quernheim, J., Sarcoidosis. Lancet 383 (2014), 1155–1167.
Treglia, G., Annunziata, S., Sobic-Saranovic, D., Bertagna, F., Caldarella, C., Giovanella, L., The role of 18F-FDG-PET and PET/CT in patients with sarcoidosis: an updated evidence-based review. Acad Radiol 21 (2014), 675–684.
Soussan, M., Augier, A., Brillet, P.Y., Weinmann, P., Valeyre, D., Functional imaging in extrapulmonary sarcoidosis: FDG-PET/CT and MR features. Clin Nucl Med 39 (2014), 146–159.
Promteangtrong, C., Salavati, A., Cheng, G., Torigian, D.A., Alavi, A., The role of positron emission tomography-computed tomography/magnetic resonance imaging in the management of sarcoidosis patients. Hell J Nucl Med 17 (2014), 123–135.
Akaike, G., Itani, M., Shah, H., Ahuja, J., Yilmaz Gunes, B., Assaker, R., et al. PET/CT in the diagnosis and workup of sarcoidosis: focus on atypical manifestations. Radiographics 38 (2017), 1536–1549.
Bergner, R., Löffler, C., Renal sarcoidosis: approach to diagnosis and management. Curr Opin Pulm Med 24 (2018), 513–520.
Horino, T., Matsumoto, T., Inoue, K., Ichii, O., Terada, Y., A case of acute kidney injury caused by granulomatous interstitial nephritis associated with sarcoidosis. CEN Case Rep 7 (2018), 34–38.
Lambert, M., Hermoye, A., Lhommel, R., Pneumo-renal sarcoidosis revealed by F-18 FDG PET/CT. NDT Plus 3 (2010), 590–591.
Toyonaga, T., Manabe, O., Gaertner, F.C., Nakagaki, T., Nishio, S., Suzuki, A., et al. Diffuse renal 18F-FDG uptake of a patient with fever of unknown origin revealed sarcoidosis. Clin Nucl Med 39 (2014), 648–649.
Goldsmith, S., Harris, M., Scherer, K., Al-Quran, S., Vorhis, E., Sarcoidosis manifesting as a pseudotumorous renal mass. J Radiol Case Rep 7 (2013), 23–34.
Heldmann, M., Behm, W., Reddy, M.P., Bozeman, C., Welman, G., Abreo, F., et al. Pseudotumoral renal sarcoid: MRI, PET, and MDCT appearance with pathologic correlation. AJR Am J Roentgenol 185 (2005), 697–699.
Elefante, E., Bond, M., Monti, S., Lepri, G., Cavallaro, E., Felicetti, M., et al. One year in review 2018: systemic vasculitis. Clin Exp Rheumatol 36:Suppl 111 (2018), S12–S32.
Lamprecht, P., Kerstein, A., Klapa, S., Schinke, S., Karsten, C.M., Yu, X., et al. Pathogenetic and clinical aspects of anti-neutrophil cytoplasmic autoantibody-associated vasculitides. Front Immunol, 9, 2018, 680.
Ozmen, O., Tatci, E., Gokcek, A., Koksal, D., Dadali, Y., Ozaydin, E., et al. Integration of 2-deoxy-2-[18F] fluoro-D-glucose PET/CT into clinical management of patients with Wegener's granulomatosis. Ann Nucl Med 27 (2013), 907–915.
Soussan, M., Abisror, N., Abad, S., Nunes, H., Terrier, B., Pop, G., et al. FDG-PET/CT in patients with ANCA-associated vasculitis: case-series and literature review. Autoimmun Rev 13 (2014), 125–131.
Kuyumcu, S., Turkmen, C., Ozluk, Y., Kiliçaslan, I., Unal, S., Microscopic polyangiitis on 18F-FDG PET/CT of a patient with fever of unknown origin presenting as isolated diffuse renal hypermetabolism. EJNMMI 40 (2013), 1295–1296.
De Geeter, F., Gykiere, P., 18FDG PET imaging in granulomatosis with polyangiitis. Hell J Nucl Med 19 (2016), 5–6.
Nelson, D.R., Johnson, G.B., Cartin-Ceba, R., Specks, U., Characterization of F-18 Fluorodeoxyglucose PET/CT in granulomatosis with polyangiitis. Sarcoidosis Vasc Diffuse Lung Dis 32 (2016), 342–352.
Kemna, M.J., Vandergheynst, F., Vöö, S., Blocklet, D., Nguyen, T., Timmermans, S.A., et al. Positron emission tomography scanning in anti-neutrophil cytoplasmic antibodies-associated vasculitis. Medicine (Baltimore), 94, 2015, e747.
Ito, K., Minamimoto, R., Yamashita, H., Yoshida, S., Morooka, M., Okasaki, M., et al. Evaluation of Wegener's granulomatosis using 18F-fluorodeoxyglucose positron emission tomography/computed tomography. Ann Nucl Med 27 (2013), 209–216.
Vaglio, A., Salvarani, C., Buzio, C., Retroperitoneal fibrosis. Lancet 367 (2006), 241–251.
Grozdic Milojevic, I.T., Milojevic, B., Sobic-Saranovic, D.P., Artiko, V.M., Impact of hybrid molecular imaging in retroperitoneal fibrosis: a systematic review. Rheumatol Int 38 (2018), 179–187.
Fernando, A., Pattison, J., Horsfield, C., D'Cruz, D., Cook, G., O'Brien, T., [18F]-fluorodeoxyglucose positron emission tomography in the diagnosis, treatment stratification, and monitoring of patients with retroperitoneal fibrosis: a prospective clinical study. Eur Urol 71 (2017), 926–933.
Caiafa, R.O., Vinuesa, A.S., Izquierdo, R.S., Brufau, B.P., Ayuso Colella, J.R., Molina, C.N., Retroperitoneal fibrosis: role of imaging in diagnosis and follow-up. Radiographics 33 (2013), 535–552.
Accorsi Buttini, E., Maritati, F., Vaglio, A., [18F]-Fluorodeoxyglucose positron emission tomography and response to therapy in idiopathic retroperitoneal fibrosis. Eur Urol 73 (2018), 145–146.
Wang, Y., Guan, Z., Gao, D., Luo, G., Li, K., Zhao, Y., et al. The value of 18F-FDG PET/CT in the distinction between retroperitoneal fibrosis and its malignant mimics. Semin Arthritis Rheum 47 (2018), 593–600.
Lovinfosse, P., Hustinx, R., Nuclear medicine techniques in transplantation. Clin Transl Imaging 5 (2017), 45–62.
Muller, N., Kessler, R., Caillard, S., Epailly, E., Hubelé, F., Heimburger, C., et al. 18F-FDG PET/CT for the diagnosis of malignant and infectious complications after solid organ transplantation. Nucl Med Mol Imaging 51 (2017), 58–68.
Loupy, A., Vernerey, D., Tinel, C., Aubert, O., Duong van Huyen, J.P., Rabant, M., et al. Subclinical rejection phenotypes at 1 year post-transplant and outcome of kidney allografts. J Am Soc Nephrol 26 (2015), 1721–1731.
Haas, M., Loupy, A., Lefaucheur, C., Roufosse, C., Glotz, D., Seron, D., et al. The banff 2017 kidney meeting report: revised diagnostic criteria for chronic active T cell-mediated rejection, antibody-mediated rejection, and prospects for integrative endpoints for next-generation clinical trials. Am J Transplant 18 (2018), 293–307.
Kurian, S.M., Williams, A.N., Gelbart, T., Campbell, D., Mondala, T.S., Head, S.R., et al. Molecular classifiers for acute kidney transplant rejection in peripheral blood by whole genome gene expression profiling. Am J Transplant 14 (2014), 1164–1172.
Paquot, F., Weekers, L., Bonvoisin, C., Pottel, H., Jouret, F., Acute kidney dysfunction with no rejection (ADNR) is associated with poor outcomes in kidney transplant recipients. Transpl Int, 30, 2017, 558.
Hanssen, O., Erpicum, P., Lovinfosse, P., Meunier, P., Weekers, L., Tshibanda, L., et al. Non-invasive approaches in the diagnosis of acute rejection in kidney transplant recipients. Part I. In vivo imaging methods. Clin Kidney J 10 (2017), 97–105.
Erpicum, P., Hanssen, O., Weekers, L., Lovinfosse, P., Meunier, P., Tshibanda, L., et al. Non-invasive approaches in the diagnosis of acute rejection in kidney transplant recipients, part II: Omics analyses of urine and blood samples. Clin Kidney J 10 (2017), 106–115.
Lovinfosse, P., Hustinx, R., Weekers, L., Jouret, F., Detry, O., The role of FDG PET in detecting rejection after liver transplantation. Surgery, 2018, 10.1016/j.surg.2018.06.014.
Watson, A.M., Bhutiani, N., Philips, P., Davis, E.G., Eng, M., Cannon, R.M., et al. The role of FDG-PET in detecting rejection after liver transplantation. Surgery 164 (2018), 257–261.
Daly, K.P., Dearling, J.L., Seto, T., Dunning, P., Fahey, F., Packard, A.B., et al. Use of [18F]FDG positron emission tomography to monitor the development of cardiac allograft rejection. Transplantation 99 (2015), e132–e139.
Reuter, S., Schnöckel, U., Schröter, R., Schober, O., Pavenstädt, H., Schäfers, M., et al. Non-invasive imaging of acute renal allograft rejection in rats using small animal 18F-FDG-PET. PLoS One, 4, 2009, e5296.
Grabner, A., Kentrup, D., Schnöckel, U., Gabriëls, G., Schröter, R., Pavenstädt, H., et al. Non-invasive imaging of acute allograft rejection after rat renal transplantation using 18F-FDG PET. J Vis Exp(74), 2013, 4240.
Reuter, S., Schnöckel, U., Edemir, B., Schröter, R., Kentrup, D., Pavenstädt, H., et al. Potential of noninvasive serial assessment of acute renal allograft rejection by 18F-FDG PET to monitor treatment efficiency. J Nucl Med 51 (2010), 1644–1652.
Lovinfosse, P., Weekers, L., Bonvoisin, C., Bovy, C., Grosch, S., Krzesinski, J.M., et al. Fluorodeoxyglucose F18 positron emission tomography coupled with computed tomography in suspected renal allograft rejection. Am J Transplant 16 (2016), 310–316.
Rabant, M., Amrouche, L., Lebreton, X., Aulagnon, F., Benon, A., Sauvaget, V., Urinary C-X-C motif chemokine 10 independently improves the noninvasive diagnosis of antibody-mediated kidney allograft rejection. J Am Soc Nephrol 26 (2015), 2840–2851.
Grabner, A., Kentrup, D., Edemir, B., Sirin, Y., Pavenstädt, H., Schlatter, E., et al. PET with 18F-FDG-labeled T lymphocytes for diagnosis of acute rat renal allograft rejection. J Nucl Med 54 (2013), 1147–1153.
Szabo, Z., Xia, J., Mathews, W.B., Brown, P.R., Future direction of renal PET. Semin Nucl Med 36 (2006), 36–50.
Päivärinta, J., Koivuviita, N., Oikonen, V., Iida, H., Liukko, K., Manner, I., et al. The renal blood flow reserve in healthy humans and patients with atherosclerotic renovascular disease measured by positron emission tomography using [15O]H2O. EJNMMI Res, 8, 2018, 45.
Juillard, L., Janier, M.F., Fouque, D., Lionnet, M., Le Bars, D., Cinotti, L., et al. Renal blood flow measurement by positron emission tomography using 150-labeled water. Kidney Int 57 (2000), 2511–2518.
Tahari, A.K., Bravo, P.E., Rahmim, A., Bengel, F.M., Szabo, Z., Initial human experience with Rubidium-82 renal PET/CT imaging. J Med Imaging Radiat Oncol 58 (2014), 25–31.
Wakabayashi, H., Werner, R.A., Hayakawa, N., Javadi, M.S., Xinyu, C., Herrmann, K., et al. Initial preclinical evaluation of 18F-Fluorodeoxysorbitol PET as a novel functional renal imaging agent. J Nucl Med 57 (2016), 1625–1628.
Mikkelsen, E.F.R., Mariager, C.Ø., Nørlinger, T., Qi, H., Schulte, R.F., Jakobsen, S., et al. Hyperpolarized [1-13C]-acetate renal metabolic clearance rate mapping. Sci Rep, 7, 2017, 16002.
Hachem, M., Tiberi, M., Ismail, B., Hunter, C.R., Arksey, N., Hadizad, T., et al. Characterization of 18F-FPyKYNE-Losartan for imaging AT1 receptors. J Nucl Med 57 (2016), 1612–1617.
Geist, B.K., Baltzer, P., Fueger, B., Hamboeck, M., Nakuz, T., Papp, L., et al. Assessing the kidney function parameters glomerular filtration rate and effective renal plasma flow with dynamic FDG-PET/MRI in healthy subjects. EJNMMI Res, 8, 2018, 37.
Gillies, R.J., Kinahan, P.E., Hricak, H., Radiomics: images are more than pictures, they are data. Radiology 278 (2016), 563–577.
Hatt, M., Tixier, F., Visvikis, D., Cheze Le Rest, C., Radiomics in PET/CT: more than meets the eye?. J Nucl Med 58 (2017), 365–366.
Lovinfosse, P., Hatt, M., Visvikis, D., Hustinx, R., Heterogeneity analysis of 18F-FDG PET imaging in oncology: clinical indications and perspectives. Clin Transl Imaging, 2018, 10.1007/s40336-018-0299-2.
Lovinfosse, P., Janvary, Z.L., Coucke, P., Jodogne, S., Bernard, C., Hatt, M., et al. FDG PET/CT texture analysis for predicting the outcome of lung cancer treated by stereotactic body radiation therapy. Eur J Nucl Med Mol Imaging 43 (2016), 1453–1460.
Lovinfosse, P., Polus, M., Van Daele, D., Martinive, P., Daenen, F., Hatt, M., et al. FDG PET/CT radiomics for predicting the outcome of locally advanced rectal cancer. Eur J Nucl Med Mol Imaging 45 (2018), 365–375.
Lovinfosse, P., Visvikis, D., Hustinx, R., Hatt, M., FDG PET radiomics: a review of the methodological aspects. Clin Transl Imaging, 2018, 10.1007/s40336-018-0292-9.